[DPHARMA] YoY TTM Result on 30-Sep-2016 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
21-Nov-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
30-Sep-2016 [#3]
Profit Trend
QoQ- -6.31%
YoY- -1.58%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Revenue 554,341 495,341 429,767 328,308 232,663 171,671 152,048 24.04%
PBT 74,528 54,833 45,270 42,709 46,157 41,729 40,017 10.91%
Tax -16,919 -9,793 -5,416 -9,379 -8,786 -7,856 -9,845 9.43%
NP 57,609 45,040 39,854 33,330 37,371 33,873 30,172 11.37%
-
NP to SH 57,609 45,277 40,548 34,022 34,569 33,873 30,172 11.37%
-
Tax Rate 22.70% 17.86% 11.96% 21.96% 19.04% 18.83% 24.60% -
Total Cost 496,732 450,301 389,913 294,978 195,292 137,798 121,876 26.37%
-
Net Worth 505,919 501,487 474,230 451,913 268,530 187,531 179,017 18.89%
Dividend
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Div 33,094 20,937 7,085 8,084 25,710 24,291 20,128 8.63%
Div Payout % 57.45% 46.24% 17.47% 23.76% 74.38% 71.71% 66.71% -
Equity
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Net Worth 505,919 501,487 474,230 451,913 268,530 187,531 179,017 18.89%
NOSH 680,106 661,881 278,959 278,959 278,959 138,912 138,773 30.31%
Ratio Analysis
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
NP Margin 10.39% 9.09% 9.27% 10.15% 16.06% 19.73% 19.84% -
ROE 11.39% 9.03% 8.55% 7.53% 12.87% 18.06% 16.85% -
Per Share
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
RPS 82.18 75.07 154.06 117.69 139.50 123.58 109.57 -4.67%
EPS 8.54 6.86 14.54 12.20 20.73 24.38 21.74 -14.41%
DPS 5.00 3.17 2.54 2.90 15.42 17.50 14.50 -16.25%
NAPS 0.75 0.76 1.70 1.62 1.61 1.35 1.29 -8.63%
Adjusted Per Share Value based on latest NOSH - 278,959
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
RPS 57.58 51.46 44.64 34.10 24.17 17.83 15.79 24.05%
EPS 5.98 4.70 4.21 3.53 3.59 3.52 3.13 11.38%
DPS 3.44 2.17 0.74 0.84 2.67 2.52 2.09 8.65%
NAPS 0.5255 0.5209 0.4926 0.4694 0.2789 0.1948 0.186 18.88%
Price Multiplier on Financial Quarter End Date
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Date 30/09/19 28/09/18 29/09/17 30/09/16 30/09/15 30/09/14 30/09/13 -
Price 1.40 1.23 2.20 2.06 2.72 3.17 2.55 -
P/RPS 1.70 1.64 1.43 1.75 1.95 2.57 2.33 -5.11%
P/EPS 16.39 17.93 15.14 16.89 13.12 13.00 11.73 5.73%
EY 6.10 5.58 6.61 5.92 7.62 7.69 8.53 -5.43%
DY 3.57 2.58 1.15 1.41 5.67 5.52 5.69 -7.47%
P/NAPS 1.87 1.62 1.29 1.27 1.69 2.35 1.98 -0.94%
Price Multiplier on Announcement Date
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Date 29/11/19 28/11/18 17/11/17 21/11/16 24/11/15 21/11/14 19/11/13 -
Price 1.39 1.07 2.20 2.10 2.70 3.01 2.56 -
P/RPS 1.69 1.43 1.43 1.78 1.94 2.44 2.34 -5.27%
P/EPS 16.28 15.59 15.14 17.22 13.03 12.34 11.77 5.55%
EY 6.14 6.41 6.61 5.81 7.68 8.10 8.49 -5.25%
DY 3.60 2.97 1.15 1.38 5.71 5.81 5.66 -7.26%
P/NAPS 1.85 1.41 1.29 1.30 1.68 2.23 1.98 -1.12%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment